-
公开(公告)号:DE60315032T2
公开(公告)日:2008-04-10
申请号:DE60315032
申请日:2003-07-16
Applicant: UCB PHARMA SA
Inventor: BROWN JULIEN ALISTAIR , BAILEY STUART , BRAND STEPHEN
IPC: C07D471/04 , A61K31/4375 , A61K31/496 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P9/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/06 , A61P43/00 , C07D221/00
Abstract: Phenylalanine enamide derivatives of formula (1) are described:wherein R is a -CH(CH3)2, -(CH2)2CH3, -CH2C(CH3)3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2OH, -CH2CH2OCH2CH2OCH3,group; and the salts, solvates and N-oxides thereof.Compounds according to the invention are potent and selective inhibitors of alpha4 integrins. The compounds are of use in modulating cell adhesion and in particular are of use in the prophylaxis and treatment of diseases or disorders including inflammation in which the extravasation of leukocytes plays a role and the invention extends to such a use and to the use of the compounds for the manufacture of a medicament for treating such diseases or disorders.
-
公开(公告)号:ES2527751T3
公开(公告)日:2015-01-29
申请号:ES07733067
申请日:2007-06-04
Applicant: UCB PHARMA SA
Inventor: ALEXANDER RIKKI PETER , BAILEY STUART , BRAND STEPHEN , BROOKINGS DANIEL CHRISTOPHER , BROWN JULIEN ALISTAIR , HAUGHAN ALAN FINDLAY , KINSELLA NATASHA , LOWE CHRISTOPHER , MACK STEPHEN ROBERT , PITT WILLIAM ROSS , RICHARD MARIANNA DILANI , SHARPE ANDREW , TAIT LAURA JANE
IPC: C07D333/66
Abstract: Un compuesto de fórmula (IIA), o una sal o solvato farmacéuticamente aceptable del mismo:**Fórmula** en la que -X1- representa un grupo de fórmula (a), (b) o (c):**Fórmula** Y representa oxígeno o azufre; R5 representa hidrógeno, halógeno, ciano, -SRa, -CORe, -CO2Rb o -CONRcRd; o R5 representa alquilo C1-6, alquenilo C2-6, alquenilcarbonilo C2-6, alquinilo C2-6, cicloalquilo C3-7, cicloalquil C3-7-alquilo (C1-6), cicloalquil C3-7- alquenilo (C2-6), cicloalquil C3-7-alquinilo (C2-6), arilo, aril-alquilo (C1-6), aril-alquenilo (C2-6), aril-alquinilo (C2-6), biarilo, heterocicloalquilo C3-7, heterocicloalquil C3-15 7-alquilo (C1-6), heterocicloalquil C3-7-alquenilo (C2-6), heterocicloalquil C3-7-alquinilo (C2-6), heterocicloalquilcarbonil C3-7-alquinilo (C2-6), heterobicicloalquil C5-9-alquinilo (C2-6), heterocicloalquil C3-7-arilo, heterocicloalquil C3-7-alquil (C1-6)-arilo, heterocicloalquil C3-7-biarilo, heteroarilo, heteroaril-alquilo (C1-6), heteroaril-alquilcarbonilo (C1-6), heteroaril-alquenilo (C2-6), heteroaril-alquinilo (C2-6), heteroaroilcarbonilo, heterocicloalquil C3-7-heteroarilo, heterocicloalquil C3-7-heteroaril-alquinilo (C2-6), heteroaril arilo, heteroaril-aril-alquilo (C1-6), aril-heteroarilo, aril-heteroaril-alquilo (C1-6), heterocicloalquil C3-7-aril-heteroarilo, heterocicloalquil C3-7-alquil (C1-6)-aril-heteroarilo, heterobicicloalquil C5-9-alquil (C1-6)-aril-heteroarilo, heteroaril-arilheteroarilo, bi(heteroarilo), heterocicloalquilcarbonil C3-7-bi(heteroarilo), ariloxiarilo, aril-alcoxiarilo (C1-6), heteroaril-alcoxiarilo (C1-6), aril-alquilaminoarilo (C1-6), heteroaril-alquilaminoarilo (C1-6), cicloalquilcarbonilaminoarilo C3-7, arilcarbonilaminoarilo, aril-alquilcarbonilaminoarilo (C1-6), heterocicloalquilcarbonilaminoarilo C3-7, heteroarilcarbonilaminoarilo, aril-heterocicloalquilcarbonilaminoarilo (C3- 7), arilsulfonilaminoarilo, aril-alquil (C1-6)-sulfonilaminoarilo, heteroaril-alquilsulfonilaminoarilo (C1-6), cicloalquilaminocarbonilaminoarilo C3-7, arilaminocarbonilaminoarilo, heterocicloalquilaminocarbonilaminoarilo C3- 7, heterocicloalquilaminocarbonilaminoarilo C3-7, heteroaril-alquilaminocarbonilaminoarilo (C1-6), heterocicloalquilcarbonilcarbonilaminoarilo C3-7, heterocicloalquil C3-7-alquilaminocarbonilcarbonilaminoarilo (C1-6), arilcarbonilarilo, heterocicloalquilcarbonilarilo C3-7, heterocicloalquilcarbonil C3-7-alquilarilo (C1-6), arilalquilaminocarbonilarilo (C1-6), heterocicloalquil C3-7-alquilaminocarbonilarilo (C1-6), heteroarilaminocarbonilarilo, heteroaril-alquilaminocarbonilarilo (C1-6), heterocicloalquilaminocarbonil C3-7-alquilarilo (C1-6), heterocicloalquil C3- 7-alquilaminocarbonil (C1-6)-alquilarilo (C1-6), heteroarilaminocarbonil-alquilarilo (C1-6), heteroarilalquilaminocarbonil( C1-6)-alquilarilo (C1-6), arilaminoheteroarilo, heterocicloalquilamino C3-7-aril-heteroarilo, heterocicloalquilcarbonilamino C3-7-aril-heteroarilo, heterocicloalquilaminocarbonilamino C3-7-aril-heteroarilo, heterocicloalquilcarbonil C3-7-aril-heteroarilo, heterocicloalquil C3-7-alquilcarbonil (C1-6)-aril-heteroarilo, heterobicicloalquilcarbonil C5-9-arilheteroarilo, heterocicloalquilcarbonil C3-7-alquil (C1-6)-aril-heteroarilo, heterocicloalquilaminocarbonil C3-7-aril-heteroarilo, heterocicloalquil C3-7-alquilaminocarbonil (C1-6)-aril-heteroarilo o heterocicloalquilaminocarbonil C3-7-alquil (C1-6)-aril-heteroarilo, cualquiera de cuyos grupos puede estar opcionalmente sustituido con uno o más sustituyentes seleccionados independientemente entre halógeno, ciano, nitro, oxo, alquilo C1-6, trifluorometilo, hidroxi, hidroxi alquilo (C1-6), alcoxi C1-6, dihidroxi-alcoxi (C1-6), aril-alcoxi (C1-6), metoxiaril-alcoxi (C1-6), amino, alquilamino C1-6, dialquilamino (C1-6), aminoalquilo (C1-6), alquilamino C1-6- alquilo (C1-6), di-alquilamino (C1-6)-alquilo (C1-6), dialquilamino (C1-6)-alquilamino (C1-6), metoxiaril-alquilamino (C1- 6), alquilcarbonilamino C1-6, alcoxicarbonil C1-6-alquilcarbonilamino (C1-6), alquilcarbonilamino C1-6-alquilo (C1-6), alcoxicarbonilamino C1-6, N-(alcoxicarbonil C1-6)-N-(alquil C1-6)amino, alcoxicarbonilamino C1-6-alquilo (C1-6), N- (alcoxicarbonil C1-6)-N-(alquil C1-6)amino-alquilo (C1-6), alquilsulfonilamino C1-6, alquilsulfonilamino C1-6-alquilo (C1- 6), alquilaminocarbonilamino C1-6, dialquilamino (C1-6)-alquilaminocarbonilamino (C1-6), N-(alquil C1-6)-N- [dialquilamino (C1-6)-alquil (C1-6)]aminocarbonilamino, carboxicarbonilamino, alcoxicarbonilcarbonilamino C1-6, alquilaminocarbonilcarbonilamino C1-6, dialquilamino (C1-6)-alquilaminocarbonilcarbonilamino (C1-6), dialquilaminosulfonilamino (C1-6), formilo, alquilcarbonilo C1-6, dialquilamino (C1-6)-alquilcarbonilo (C1-6), carboxi, carboxi-alquilo (C1-6), alcoxicarbonilo C1-6, alcoxicarbonil C1-6-alquilo (C1-6), aminocarbonilo, alquilaminocarbonilo C1-6, dialquilaminocarbonilo (C1-6), cianoalquilaminocarbonilo (C1-6), di-alquilamino (C1-6)-alquilaminocarbonilo (C1- 6), dihidroxi-alquilaminocarbonilo (C1-6), N-(alquil C1-6)-N-[aminoalquil (C1-6)]aminocarbonilo, N-(alquil C1-6)-N
-
公开(公告)号:AU2003280965B2
公开(公告)日:2008-10-09
申请号:AU2003280965
申请日:2003-07-16
Applicant: UCB PHARMA SA
Inventor: BRAND STEPHEN , BROWN JULIEN ALISTAIR , BAILEY STUART
IPC: C07D471/04 , A61K31/4375 , A61K31/496 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P9/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/06 , A61P43/00
Abstract: Phenylalanine enamide derivatives of formula (1) are described:wherein R is a -CH(CH3)2, -(CH2)2CH3, -CH2C(CH3)3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2OH, -CH2CH2OCH2CH2OCH3,group; and the salts, solvates and N-oxides thereof.Compounds according to the invention are potent and selective inhibitors of alpha4 integrins. The compounds are of use in modulating cell adhesion and in particular are of use in the prophylaxis and treatment of diseases or disorders including inflammation in which the extravasation of leukocytes plays a role and the invention extends to such a use and to the use of the compounds for the manufacture of a medicament for treating such diseases or disorders.
-
公开(公告)号:ES2290477T3
公开(公告)日:2008-02-16
申请号:ES03740814
申请日:2003-07-16
Applicant: UCB PHARMA SA
Inventor: BROWN JULIEN ALISTAIR , BAILEY STUART , BRAND STEPHEN
IPC: C07D471/04 , A61K31/4375 , A61K31/496 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P9/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/06 , A61P43/00 , C07D221/00
Abstract: Un compuesto de fórmula (1) (Ver fórmula) en la que R 1 es un grupo -CH(CH3)2, -(CH2)2CH3, -CH2C(CH3)3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2 OH, -CH2CH2OCH2CH2OCH3, (Ver fórmula) y las sales, solvatos y N-óxidos del mismo.
-
5.
公开(公告)号:SI1370531T1
公开(公告)日:2007-08-31
申请号:SI200230546
申请日:2002-01-18
Applicant: UCB PHARMA SA
Inventor: BAILEY STUART , BROWN JULIEN , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: C07D213/00 , A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/81 , C07D213/89 , C07D401/00 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/00 , C07D471/04
-
公开(公告)号:ES2282403T3
公开(公告)日:2007-10-16
申请号:ES02715515
申请日:2002-01-18
Applicant: UCB PHARMA SA
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: C07D213/81 , A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/36 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04
Abstract: Un compuesto de **fórmula**, en la que Ar1 es un grupo aromático o heteroaromático opcionalmente sustituido; en el que los sustituyentes opcionales se seleccionan de uno, dos o tres átomos de halógeno, y/o grupos alquiloC1-6, cicloalquiloC3-8, hidroxialquilo1-6, carboxialquiloC1-6, alquilC1-6tio, carboxialquilC1-6tio, alcoxiC1-6, hidroxialcoxiC1-6, haloalquiloC1-6, haloalcoxiC1-6, alquilC1-6amino, -NH2, aminoalquiloC1-6, dialquilC1-6amino, alquilC1-6amino-alquiloC1-6, dialquilC1-6amino-alquiloC1-6, aminoalcoxiC1-6, alquilC1-6amino-alcoxiC1-6, dialquilC1-6amino-alcoxiC1-6, nitro, ciano, amidino, -OH, HC(O)-, -CO2H, -CO2R5, alcanoíloC1-6, -SH, tioalquiloC1-6, -SO3H, -SO2R5, alquilC1-6sulfinilo, alquilC1-6sulfonilo, -SO2NH2, alquilC1-6aminosulfonilo, dialquilC1-6aminosulfonilo, fenilaminosulfonilo, -CONH2, alquilC1-6aminocarbonilo, dialquilC1-6aminocarbonilo, aminoalquilC1-6aminocarbonilo, alquilC1-6aminoalquilC1-6aminocarbonilo, dialquilC1-6aminoalquilC1-6aminocarbonilo, aminocarbonilamino, alquilC1-6aminocarbonilamino, dialquilC1-6aminocarbonilamino, alquilC1-6amino-carbonilalquilC1-6amino, aminotiocarbonilamino, alquilC1-6aminotiocarbonilamino, dialquilC1-6aminotiocarbonilamino, alquilC1-6aminotiocarbonilalquilC1-6amino, alquilC1-6sulfonilamino, dialquilC1-6sulfonilamino, -NHSO2NH2, alquilC1-6aminosulfonilamino, dialquilC1-6aminosulfonilamino, alcanoC1-6ilamino, aminoalcanoC1-6ilamino, dialquilC1-6aminoalcanoC1-6ilamino, alcanoC1-6ilaminoC1-6alquilo, alcanoC1-6ilaminoalquilC1-6amino o alcoxiC1-6carbonilamino; R5 es un átomo de hidrógeno, o un grupo alquiloC1-6 o cicloalquiloC3-8; L2 es un enlace covalente o un grupo L2a o -(Alc3)L2a, en el que Alc3 es una cadena alifática o heteroalifática opcionalmente sustituida y L2a es un átomo de -O- o -S- o un grupo -C(O)-, -C(O)O-, -C(S)-, -S(O)-, -S(O)2-, -N(R8)- [en el que R8 es un átomo de hidrógeno o un grupo alquiloC1-6 lineal o ramificado], -CON(R8)-, -OC(O)N(R8)-, -CSN(R8)-, -N(R8)CO-, -N(R8)C(O)O-, -N(R8)CS-, -S(O)2N(R8)-, -N(R8)S(O)2-, -N(R8)O-, -ON(R8)-, -N(R8)N(R8), -N(R8)CON(R8)-, -N(R8)CSN(R8), o -N(R8)SO2N(R8)-; los sustituyentes opcionales que pueden estar presentes en Alc3 se seleccionan de uno, dos o tres sustituyentes donde cada sustituyente puede ser el mismo o diferente y se selecciona de átomos de halógeno, o grupos -OH, -CO2H, -CO2R9, donde R9 es un grupo alquiloC1-6 lineal o ramificado, -CONHR9, -CON(R9)2, -COR9, alcoxiC1-6, tiol, -S(O)R9, -S(O)2R9, alquiltioC1-6, amino, -NHR9 o -N(R9)2; Ar2 es un grupo arileno o heteroarileno opcionalmente sustituido; en el que los sustituyentes opcionales que pueden estar presentes en Ar2 se seleccionan de átomos de halógeno, o grupos alquiloC1-6, halo alquiloC1-6, alcoxiC1-6, haloalcoxiC1-6, -CN, -CO2CH3, -NO2, -NH2, -NR5R6 y -N(R5)COCH3; R6 es como se definió para R5; y Alc es una cadena -CH2-CH(R)-, -CH=C(R)- y las sales, solvatos, hidratos y N-óxidos del mismo.
-
7.
公开(公告)号:AU2002225163B2
公开(公告)日:2007-08-02
申请号:AU2002225163
申请日:2002-01-18
Applicant: UCB PHARMA SA
Inventor: PORTER JOHN ROBERT , BRAND STEPHEN , BAILEY STUART , JOHNSON JAMES ANDREW , HEAD JOHN CLIFFORD , BROWN JULIEN ALISTAIR
IPC: C07D213/81 , A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R 1 , R x , R y , R z , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
公开(公告)号:NO326554B1
公开(公告)日:2009-01-12
申请号:NO20033710
申请日:2003-08-20
Applicant: UCB PHARMA SA
Inventor: PORTER JOHN ROBERT , BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , HEAD JOHN CLIFFORD
IPC: C07D213/81 , A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R 1 , R x , R y , R z , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
-
-
-
-
-
-